Evidence map›Paper›PMID 23028619›Full record

ArticlePloS one2012

Biologically-directed modeling reflects cytolytic clearance of SIV-infected cells in vivo in macaques.

W David Wick, Otto O Yang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. CD8Nature communications · 2023
    Article
  3. Article
  4. Modeling the immune response to HIV infection.Current opinion in systems biology · 2018
    Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

W David WickVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. wdavid.wick@gmail.com
Otto O Yang
Infectious Disease Research Institute · USUniversity of California, Los Angeles · US

Funding

HIV-1 Excape from Inhibiton by Cytotoxic T LymphocytesR01AI043203 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, OTTO O · 1998 to 2012
$4.6M
Immune Pressure on HIV-1 Nef by Cytotoxic T LymphocytesR01AI051970 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, OTTO O · 2002 to 2011
$4.1M
Tools for Testing HIV Immune-Control and Vaccine ModelsR01AI054280 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI WICK, W DAVID · 2003 to 2009
$1.0M
NIAID NIH HHS AI043203NIAID NIH HHS AI051970NIAID NIH HHS AI054280NIAID NIH HHS R01 AI043203NIAID NIH HHS R01 AI051970NIAID NIH HHS R01 AI054280
6 · The paper itself

Abstract

The disappointing outcomes of cellular immune-based vaccines against HIV-1 despite strong evidence for the protective role of CD8⁺ T lymphocytes (CTLs) has prompted revisiting the mechanisms of cellular immunity. Prior data from experiments examining the kinetics of Simian Immunodeficiency Virus (SIV) clearance in infected macaques with or without in vivo CD8 depletion were interpreted as refuting the concept that CTLs suppress SIV/HIV by direct killing of infected cells. Here we briefly review the biological evidence for CTL cytolytic activity in viral infections, and utilize biologically-directed modeling to assess the possibility of a killing mechanism for the antiviral effect of CTLs, taking into account the generation, proliferation, and survival of activated CD4⁺ and CD8⁺ T lymphocytes, as well as the life cycle of the virus. Our analyses of the published macaque data using these models support a killing mechanism, when one considers T lymphocyte and HIV-1 lifecycles, and factors such as the eclipse period before release of virions by infected cells, an exponential pattern of virion production by infected cells, and a variable lifespan for acutely infected cells. We conclude that for SIV/HIV pathogenesis, CTLs deserve their reputation as being cytolytic.

Indexed as

Models, BiologicalAnimalsAnti-Retroviral AgentsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DeathCell ProliferationMacacaSimian Immunodeficiency VirusSpecies SpecificityTime FactorsViremiaVirus ReplicationAnti-Retroviral Agents

Identifiers

PMID23028619
PMCPMC3441463
OpenAlexW1995882748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.